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1152Background: The Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (GTSD) is the
largest clinical thoracic surgical database in the United States. The purpose of the present study was to determine
whether the GTSD esophagectomy outcomes are representative of nationwide outcomes by comparing them
with other national clinical and administrative databases.
Methods: From 2002 to 2008, esophageal cancer resection outcomes from the GTSDwere compared with those
from the National Surgery Quality Improvement Program (NSQIP) and Nationwide Inpatient Sample (NIS). The
observed differences in patient characteristics and postoperative events were also analyzed.
Results: Annual esophageal resection volumes have increased over time. However, as of 2008, the GTSD and
NSQIP only capture a small proportion of resections performed nationally (36% and 11%, respectively). The
median patient age and female gender were similar in all 3 databases. Mortality was significantly lower within
the GTSD (3.2%) and NSQIP (2.6%) compared with the NIS (6.1%, P<.001). The median length of stay was
lower in the GTSD (10 days) than in either the NSQIP (12 days) and NIS (12 days, P<.001).
Conclusions: The STS GTSD reports outstanding mortality results and hospital length of stay for esophageal
cancer resection. However, the surgical outcomes from the STS GTSD are not representative of the national re-
sults from programs not participating in the database. These results establish a reference for future esophagec-
tomy comparisons and highlight the importance of increased participation and use of the STS GTSD. (J Thorac
Cardiovasc Surg 2012;144:1152-9)Esophageal cancer has accounted for an increasing number
of cancer-related deaths in the United States during the past
few decades. According to the American Cancer Society,
esophageal cancer affects approximately 5 in 100,000 US
citizens.1 Despite improvements in surgical outcomes, re-
cent reports of morbidity and mortality have ranged from
10% to 40% and 0% to 15%, respectively.2 As patient out-
comes improve, the need for consistent clinical documenta-
tion and data gathering are required to help guide future
treatment decisions and clinical research.
Significant progress has been achieved in the documenta-
tion of patient characteristics and outcomes within both ad-
ministrative and clinical databases. These databases have
facilitated substantial benefits by improving patient care
and guiding clinical investigation. However, the content
and purpose of these various databases have significante Division of Thoracic and Cardiovascular Surgery, University of Virginia
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The Journal of Thoracic and Cardiovascular Surdifferences. Currently, the Nationwide Inpatient Sample
(NIS) serves as the largest, most representative and publicly
available administrative database within the United States.3
Consisting of inpatient discharge records, the NIS reports
patient- and hospital-level details and disposition and
mortality data. Using the ‘‘International Classification
of Diseases, Ninth Revision, Clinical Modifications’’
(ICD-9-CM)–based coding system, the NIS provides an
estimate of nationwide trends for patients undergoing
medical and surgical admissions within the United
States. Among the clinical databases, the American Col-
lege of Surgeons (ACS) National Surgical Quality Initia-
tive Program (NSQIP) and the Society of Thoracic
Surgeons (STS) General Thoracic Surgery Database
(GTDB) represent 2 leading surgical databases specifi-
cally designed to capture and report general surgery
and thoracic surgery outcomes, respectively. The ACS
NSQIP was established in 2005 and is a nationally vali-
dated, risk-adjusted, outcomes-based program intended
to quantify the surgical outcomes and metrics of quality
surgical care. Approximately one half of the participating
centers in the NSQIP are community hospitals.4
The STS GTDB was initiated in 2002 and has demon-
strated excellent surgical outcomes for esophageal cancer
resection.5 The STS GTDB is the largest clinical thoracic
surgical database in the United States. However, it is not
known whether the outstanding outcomes for esophageal
cancer resection from the GTDB are representative ofgery c November 2012
Abbreviations and Acronyms
ACS ¼ American College of Surgeons
GTDB ¼ General Thoracic Surgery Database
ICD-9-CM ¼ ‘‘International Classification of
Diseases, Ninth Revision, Clinical
Modifications’’
NIS ¼ Nationwide Inpatient Sample
NSQIP ¼ National Surgical Quality Initiative
Program
STS ¼ Society of Thoracic Surgeons
LaPar et al General Thoracic Surgerynationwide results. The purpose of the present study was to
determine whether the GTDB esophagectomy outcomes are
representative of the nationwide outcomes by directly com-
paring themwith those reported in other clinical and admin-
istrative databases. We hypothesized that the GTDB would
only capture a few of the procedures performed nationally
and that it would report superior outcomes compared with
those reported in the NSQIP and NIS databases.G
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Data obtained for the present study were extracted from the NIS and STS
GTDB for 2002 to 2008. The ACS NSQIP did not begin until 2005, and data
were extracted for 2005 to 2008. The present study was exempt from formal
review by the University of Virginia institutional review board, because they
deemed itwasnot human subjects researchowing to the lackof discretepatient
identifiers and because the analyzed datawere not exclusively collected for re-
search purposes. The patient records for those undergoing esophageal resec-
tionwith a diagnosis of esophageal cancer were extracted from each database.Patient Selection
Within the NIS, appropriate discharge records were identified by query-
ing the first 5 diagnosis and procedure categories using the following
ICD-9-CM procedure and diagnosis codes: primary esophageal cancer
(ICD-9-CM diagnosis code 150.X) and esophageal resection (ICD-9-CM
procedure codes 42.4, 42.40, 42.41, 42.42, and 43.99). The ACS NSQIP
and STS GTDB were queried for all patient records for those undergoing
primary esophageal cancer resection during the study period. Datawere ex-
cluded for patients with benign esophageal disease. During data extraction
from the NIS data sets, fewer than 1% of patient records with missing data
for patient age, gender, and mortality underwent case wise deletion to
obtain a complete data set for analysis.
Variable and Outcome Definitions
All variable definitions conformed to those used within the NIS, NSQIP,
and GTDB.3,4,6 All measured outcomes were established a priori before
data analysis. The primary outcomes of interest were the differences in
the reported frequency of esophageal cancer resection among the 3
databases and the observed differences in discharge mortality and
hospital length of stay. Mortality was defined differently among these 3
databases. The NIS and NSQIP report in-hospital mortality and the
GTDB reports 30-day mortality.
Statistical Analysis
All statistical methods were designed to test the null hypothesis that the
outcomes after esophageal cancer resection would not be significantlyThe Journal of Thoracic and Cardifferent. Standard statistical significance was set to an a of 0.05. Descrip-
tive statistics for all variable comparisons were calculated using appropri-
ate univariate hypothesis tests. Categorical variables are expressed as
within group percentages and were compared for independent samples us-
ing either Pearson’s c2 or Fisher’s exact test. Continuous variables are ex-
pressed as either the mean  standard deviation or median and
interquartile range, depending on the overall variable distribution.
Independent-sample, single-factor analysis of variance was used for para-
metric data comparisons, and the Mann-Whitney U test was used for all
nonparametric data comparisons, where appropriate. Calculated test statis-
tics were used to derive all reported 2-tailed P values. All statistical anal-
yses were performed using Predictive Analytics SoftWare (PASW),
version 18 (IBM Corp, Somers, NY).
RESULTS
The total number of esophageal cancer resections varied
widely among the 3 databases (NIS, 22,758; GTDB, 6740;
NSQIP, 1030; Table 1). The median patient age was 63
years in the GTDB, 65 years in the NSQIP, and 64 years
in the NIS (P<.001). Women underwent a lower frequency
of esophageal resection than men in each database. Table 1
also illustrates significant differences in comorbidity among
the databases. Of note, the GTDB had a greater prevalence
of chronic obstructive pulmonary disease, congestive heart
failure, and renal failure than did the NSQIP, the other clin-
ical database included for comparison (P<.001).
When examining the annual volume of esophageal can-
cer resections, the volume of procedures reported increased
within all 3 databases (Figure 1). The NIS volumes in-
creased from 2822 operations annually in 2002 to 3728 op-
erations annually in 2008. Esophageal cancer resection
frequency consistently increased during the study period
within the GTDB and NSQIP but as of 2008 only repre-
sented a small proportion (36% and 11%) of the estimated
resections performed annually nationwide (Figure 1).
When comparing the primary outcomes, the GTDB re-
ported superior mortality and hospital length of stay com-
pared with the NIS administrative data (Table 2).
Discharge mortality in the GTDB and NSQIP was 3.2%
and 2.6%, respectively, which was significantly lower
than discharge mortality reported within the NIS (6.1%,
P<.001). In addition, the trends in mortality were lower
(P< .001) in the GTDB and NSQIP for each operative
year throughout the study period (Figure 2). The median
hospital length of stay for the GTDB was 2 days less than
that in the NSQIP and NIS (GTDB, 10 days vs NSQIP, 12
days vs NSQIP, 12 days; P<.0001).
DISCUSSION
We present an important nationwide comparison of the
performance of esophageal cancer resection and outcomes
as reported within 2 clinical databases, the STS GTDB
and the ACS NSQIP, and the most broadly representative
administrative database, the NIS. Our results have demon-
strated that significant differences exist in reported patient
characteristics, esophageal cancer resection frequency,diovascular Surgery c Volume 144, Number 5 1153
TABLE 1. Patient demographics and risk factors for esophageal
cancer resection as reported in 3 databases
Factor
GTDB
(n ¼ 6740)
NSQIP
(n ¼ 1030)
NIS
(n ¼ 22,758)
P
value
Age (y) .04
Median 63 65 64
Interquartile range 55-70 56-72 56-72
Gender <.0001
Male 82.0% 79.0% 83.0%
Female 18.0% 21.0% 17.0%
Year of surgery <.0001
2002 152 — 2822
2003 514 — 3058
2004 579 — 2487
2005 614 52 3572
2006 887 209 3074
2007 1162 367 4017
2008 1349 402 3728
Comorbid disease
Hypertension 48.3% 50.9% 40.6% <.0001
Heart failure 2.1% 0.2% 4.8% <.0001
Chronic lung disease 12.7% 6.7% 20.7% <.0001
Renal failure 1.6% 0.2% 2.2% <.0001
GTDB, General Thoracic Surgery Database; NSQIP,National Surgical Quality Initia-
tive Program; NIS, Nationwide Inpatient Sample.
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Sand outcomes, as reported by these 3 databases. The number
of annual resections reported by the GTDB and NSQIP con-
sistently increased over time. However, the number of
esophageal cancer resections reported within both clinical
databases only represented a few of the estimated nation-
wide esophagectomies, as reported by the NIS. Postopera-
tive mortality was significantly better for the clinical
databases, and the GTDB reported the lowest hospitalFIGURE 1. Annual esophageal cancer resection volume recorded in General
Program (NSQIP), and Nationwide Inpatient Sample (NIS) databases (P<.001)
1154 The Journal of Thoracic and Cardiovascular Surlength of stay. These results have significant implications
for on the current and future utility of the GTDB compared
with the other available clinical and administrative data-
bases as instruments for clinical practice and investigation.
The GTDB is a leading clinical and academic resource
within thoracic surgery, providing an important platform
from which to perform comparative effectiveness studies
and surgical quality assessment. Several GTDB-based stud-
ies have recently analyzed and tracked operative outcomes
after lung and esophageal resection.5,7-11 Among the
esophageal cancer resection data, the GTDB has recently
been used to identify predictors of major morbidity and
mortality and to compare hospital performance variation.5
In their analysis of the GTDB, Wright and colleagues5 ex-
amined more than 2315 esophageal cancer resection cases
from 73 different participating centers from 2002 to 2007.
Similar to the present findings, their results demonstrated
lower hospital mortality (2.7%) than that reported by ad-
ministrative databases. In their study, the most significant
predictors of major morbidity and mortality after esopha-
gectomy were female gender, current cigarette use, and
patient comorbidities. Their analyses also demonstrated
significant hospital performance variation in risk-adjusted
rates of major morbidity and mortality after esophagec-
tomy. Of note, the differences in hospital performance var-
iation were not associated with hospital procedure volume.
Wright and colleagues5 evaluated this relationship using
a participant’s average annual procedure volume and, de-
spite a large variation in hospital procedure volume, it
was not a significant predictor of mortality or major morbid-
ity. This finding is very similar to recent work reported by
Kozower and Stukenborg12 examining esophageal cancer
resection in the NIS. Their study used administrative dataThoracic Surgery Database (GTDB), National Surgical Quality Initiative
. ACS, American College of Surgeons; STS, Society of Thoracic Surgeons.
gery c November 2012
TABLE 2. Postoperative morbidity, mortality, and resource use after
esophageal cancer resection as reported in 3 databases
Outcome
GTDB
(n ¼ 6740)
NSQIP
(n ¼ 1030)
NIS
(n ¼ 22,758)
P
value
Mortality 3.2% 2.6% 6.1% <.0001
Length of stay (d) <.0001
Median 10 12 12
Interquartile range 8-15 9-19 9-19
GTDB, General Thoracic Surgery Database; NSQIP, National Surgical Quality
Initiative Program; NIS, Nationwide Inpatient Sample.
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Sand evaluated the relationship between in-hospital mortality
and hospital volume using 3 different techniques for mea-
suring hospital volume. Similar to the clinical study using
STS data, Kozower and Stukenborg12 demonstrated that
the hospital esophagectomy volume was not a predictor of
mortality and that the most important predictors of mortal-
ity were patient age and comorbidities.
A principle finding of the present study was the striking
differences in the reported frequencies of esophageal cancer
resection among the databases. The NIS was used in the
present analysis to provide a valid nationwide estimate of
esophageal cancer resection rates from which to compare
the GTDB and NSQIP. To ensure a valid analysis of the
data contained within each database, comparisons were
made for years with available data from both the GTDB
and the NIS (2002-2008) and for the years in which the
NSQIP had available data (2005-2008). The reported fre-
quency of annual esophageal cancer resection rates within
the NIS in the present study was similar to that reported
in other published series.13,14 A recent series from Kohn
and colleagues14 reported on national trends and outcomes
among 57,676 patients undergoing esophagectomy withinFIGURE 2. Annual mortality after esophageal cancer resection as recorded i
Initiative Program (NSQIP), and Nationwide Inpatient Sample (NIS) databases
The Journal of Thoracic and Carthe NIS from 1998 to 2006. Connors and associates13 re-
ported similar esophageal resection volumes in their com-
parison of transthoracic and transhiatal esophagectomy
among 17,395 patients from 1999 to 2003. With respect
to the reported NSQIP volume, Dhungel and colleagues15
recently reported resection volumes equal to that of the
present analysis in their identification of predictors of mor-
bidity and mortality after esophageal resection. Thus, the
important finding that, as of 2008, the GTDB and NSQIP
only represent 36% and 11%, respectively, of estimated
esophageal cancer resections performed within the United
States annually provides an important context from which
to view the reported results.
The reported mortality and hospital length of stay in the
present study are similar to those from other published
esophageal cancer resection reports.2,5,13-16 In the present
series, the hospital discharge mortality rates ranged from
2.6% in the NSQIP and 3.2% in the GTDB to 6.1% in the
NIS. Other nationwide series have documented mortality
rates for esophageal cancer resection of 6% to 12%,13,14
and smaller, single-institution mortality rates have ranged
from 0.0% to 15%.2,17 Regarding the hospital length of
stay, current US nationwide reports for esophagectomy are
lacking in recently reported data. However, the results of
the present study have demonstrated a median length of
stay of 10 to 12 days, comparable to other single-
institution reports and meta-analyses.17-19 More
importantly, the principal findings in the present analysis
were the significant differences found between the clinical
and administrative database outcomes and the low
mortality rate and reduced hospital length of stay reported
within the GTDB. The significance of the outstanding
outcomes and the proportionately small percentage ofn General Thoracic Surgery Database (GTDB), National Surgical Quality
(P<.001).
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FIGURE 3. Annual number of General Thoracic Surgery Database
(GTDB) hospital participants.
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Scases captured within the GTDB is that these outcomes are
not currently generalizable to all patients in the United
States. A likely explanation for these differences is that
clinical databases include a greater proportion of outcomes
from dedicated, experienced thoracic and/or general
surgeons, often practicing at tertiary care centers.
Moreover, it should be noted that the clinical implications
of the slightly longer hospital length of stay reported for
patients within the NSQIP and NIS compared with the
GTDB likely impart a small effect on overall resource
usage, because most costs associated with hospitalizations
occur from complications commonly occurring in the first
few postoperative days.20
Although the GTDB might not ever represent ‘‘general-
ized’’ outcomes throughout the United States for nonpartic-
ipating, nonthoracic surgeons, we do believe that increased
participation in the GTDB is needed to establish its place
among available clinical registries and to provide a more ac-
curate measure of outcomes for participating centers. These
data demonstrate that future analyses of GTDB esophagec-
tomy outcomes should recognize the context from which
these outcomes should be considered. Furthermore, because
of the present results, future comparisons of GTDB out-
comes with other surgical databases, including the NSQIP,
and reported nationwide outcomes are warranted to estab-
lish its evolving generalizability, and comparisons of future
predictive modeling using these clinical and administrative
databases might be feasible.21 In addition, recent work ex-
amining the generalizability of the GTDB in lung cancer re-
section showed similar results with the GTDB, representing
a small percentage of procedures performed nationally
(NIS) but having significantly lower mortality and hospital
length of stay.22 These data suggest that the reported supe-
rior GTDB outcomes, reflecting the expertise of trained,
dedicated thoracic surgeons at tertiary referral hospitals,
should not be extrapolated to other general and/or thoracic
surgeons and centers not participating in the GTDB.
The reported results have significant clinical implications
to support increased participation in the GTDB by US hos-
pitals and thoracic surgeons. Since its introduction, there
has been a consistent increase in the number of GTDB par-
ticipating centers. This increase has been exponential with
a dramatic increase in participation within the past 3 to 5
years (Figure 3). This increased participation is directly re-
flected by the increase in esophageal cancer resections per-
formed during the study period. More importantly, however,
the superior results of the GTDBwe have reported highlight
the critical importance of increased participation in the
GTDB to not only allow for improved generalizability of
its nationwide outcomes, but also to provide a better bench-
mark for esophagectomy outcomes by well-trained sur-
geons and experienced centers.
The present study had several limitations. The retrospec-
tive study design is subject to inherent selection bias. A1156 The Journal of Thoracic and Cardiovascular Sursecond limitation was that different definitions for patient
and outcome variables were used in the GTDB, NSQIP,
and NIS. Mortality is defined as in-hospital death in
the NIS and NSQIP and as 30-day mortality by the
GTDB. Also, the 30-day mortality is likely to be lower
than in-hospital mortality, and this comparison might un-
derestimate the outstanding results of the GTDB.23 Addi-
tional differences in data content among the 3 databases
limited comparisons of specific predictors of surgical out-
comes. Detailed patient characteristics remain well-
established risk factors for morbidity and mortality after
esophageal cancer resection, and many are included in the
STS GTDB mortality risk models. Although no precise
method is available to determine the specialty practice of
surgeons included in these databases, the assumption that
a larger percentage of general surgeons are represented in
the NSQIP database should be considered. The potential
for unrecognized miscoding and data entry errors should
be considered in any secondary analysis of data registries.
Furthermore, these databases could have some overlap,
such that the same patient could be included in more than
1 database. Although external auditing of the GTDB began
in 2010, it was not performed for the included study period.
However, auditing of the STS adult cardiac database has
demonstrated 95% accuracy. Finally, long-term follow-up
data are lacking in these databases. Despite these limita-
tions, our results have provided an important contribution
to the existing esophagectomy data by providing a bench-
mark for future GTDB and other database comparisons.CONCLUSIONS
The present study has demonstrated that significant dif-
ferences exist between annual procedure volumes and out-
comes for esophageal cancer resection reported in clinical
and administrative databases. The STS GTDB has reported
outstanding mortality results and reduced hospital length of
stay for esophageal cancer resection. However, the surgical
outcomes from the STS GTDB are not representative of the
national results from programs not participating in the
database. These results establish a reference for futuregery c November 2012
LaPar et al General Thoracic Surgeryesophagectomy comparisons and highlight the importance
of increased participation and use of the STS GTDB.
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Dr Antoon Lerut (Leuven, Belgium). Congratulations on this
excellent presentation and thank you for sending me the manu-
script well in advance.
I consider this type of study as being a typical sort of playground
for investigators with a master’s degree in public health or holding
some other master’s degree in science, all of which I am not. That
is the only disclosure I have to make. Also, I noticed that this is the
fifth presentation in this meeting of a report that to some extent re-
lates to the topic of volume and outcomes. That is about 10% of all
presentations, which I think comes close to the definition of an ep-
idemic. But, anyway, I will give it a try.
My first observation is that the number of surgeries for esopha-
geal cancer registered, and I presume these are the factual surger-
ies, are increasing steadily in all databases. The second observation
is that the mortality is decreasing slowly, and except for the year
2008 that was in the report, this figure is most prominent in the
NIS database, decreasing from 8% in 2002 to 3% in 2007, closing
the gap between the NIS and the 2 other databases. I would say that
is good news for the patients and also for the surgeons.
I have 3 questions. First, you indicated that comorbidities, such
as chronic obstructive pulmonary disease (COPD), which are seen
as risk factors for esophageal cancer resection were greater in the
GTDB than in the NSQIP database. I wonder whether these data-
bases use the same definitions for the values related to each of the
comorbidities. For example, COPD Global Initiative for Chronic
Obstructive Lung Disease class 1 and COPD Global Initiative
for Chronic Obstructive Lung Disease class 2 both match the def-
inition of COPD but clearly represent differing severity of the dis-
ease. That could, of course, be a source a bias. In other words, are
you comparing the same severity of disease for each of these
comorbidities?
Dr Kozower. Thank you very much for your comments. As you
correctly point out, the definitions for various comorbidities, such
as COPD, are different for the different databases. Wewere careful
to point this out and tried not to overinterpret the data.
Dr Lerut. The second question relates to the fact that for about
2 decades the relationship between procedure volume and better
outcome has been accepted; however, more recently, it has been
postulated that volume per se does not translate into better out-
comes. Rather, it is the factors associated with it, such as surgeon
expertise, perioperative management, and so forth. Therefore,
procedure volume should not be used as a measure of quality, as
Dr LaPar from your group so strongly advocated last Friday atdiovascular Surgery c Volume 144, Number 5 1157
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the GTDB and the NSQIP database include a number of low-vol-
ume centers. Because both databases show a very low mortality
rate, this seems to confirm that volume on its own is an inadequate
parameter of quality measurement. Nevertheless, we keep hearing
that esophagectomy needs to be centralized to high-volume cen-
ters, and I think all of us would like to be operated for esophageal
carcinoma in a high-volume center. So, if it is not volume, what is
it that we should bring forward to endorse such a plea in favor of
centralization? What do we have to advise to our healthcare poli-
cymakers, because they are using that type of data.
Dr Kozower. Your question is obviously a very important one,
but you are asking me for kind of the ‘‘Holy Grail’’ of quality.
However, we do not fully understand what distinguishes high-
and low-performing hospitals. I think expertise is obviously ex-
tremely important and quality is a multidimensional concept. So
what we have argued so strongly against is trying to oversimplify
it and simply use volume as a proxy for quality, particularly when
that alone will be used to direct patient referrals. However, factors
are present at these high-volume hospitals that are associated with
good outcomes. Thus, our group and others are currently working
to identify these factors.
Dr Lerut.Well, I would think that is a lot of work ahead, but I
think it is important that we try to find these elements, because that
is not what the policymakers and insurance companies are using.
Also, as I said, I presume that everybody in this room would like
to be operated in a high-volume center rather than in a low-volume
center. So volume does matter, right?
Dr Kozower. I do not think the data support using volume as
a proxy for quality. Even using the STS GTDB, when you consider
Cam Wright’s paper on esophagectomy, volume was not a signifi-
cant predictor of mortality or major morbidity. Importantly, more
than one half of the centers are what are classically thought of as
low volume, and the results are more generalizable.
Dr Lerut. You mentioned that the GTDB and the NSQIP data-
base represent only a small proportion, 36% and 11%, respectively,
of the estimated number of resections performed nationwide.
Given the comparable results, is it not time to link those 2 databases
to generate a larger effort and therefore a stronger sample? This
would allow us to better convince the outside world that patients
should be treated by board-certified surgeons, whether thoracic
surgeons or specialist upper gastrointestinal surgeons. I come
from a part of the world where I am more frequently confronted
with the fact that upper gastrointestinal surgeons are involved in
performing this type of surgery with excellent results. I would
like to hear your comments on how you see this in this country.
Dr Kozower. While I am not in charge of setting US policy, I
strongly believe that it is the surgical outcomes that should be
used to judge the surgeon and not any arbitrary predictor. There-
fore, it is going to be very important for us to determine how to
measure and differentiate surgical and hospital performance. The
STS database has demonstrated significantly better outcomes,
and so it is not hard to convince this crowd that esophageal cancer
should be performed by those of us sitting in the room. How do you
do that for the whole country, and are we actually available to the
whole country? These are very complicated issues. Canada is start-
ing to figure this out, and they have been presenting their series
with regionalization of care. Some of the results seem quite1158 The Journal of Thoracic and Cardiovascular Surgood and some of them actually have not shown as large a decrease
in mortality as one might think.
Dr Lerut. Would you make an effort to combine the 2 data-
bases and try to come up with a greater percentage and therefore
be able to make stronger statements on just the idea to centralize
patients?
Dr Kozower. I do not think I would want to combine the 2 da-
tabases, because they have very different purposes. The NSQIP
was established for general and vascular surgery and uses a sam-
pling method to capture thoracic procedures, such as esophagec-
tomy, performed at a given hospital. Certain hospitals use the
NSQIP to capture every case they perform, but, overall, that is
not the sampling method.
Dr Lerut. I thank the Association for the privilege to discuss
this paper.
Dr David J. Sugarbaker (Boston, Mass). I have 1 question and
comment regarding the STS database and NSQIP or the adminis-
trative, and that is that I am not sure people are aware that the fun-
damental difference between the NSQIP and STS database, and
one of the disadvantages of the STS database, could be that it
uses elective data submission. So, the data submission for STS is
retrospective, occurring after the procedure, usually after dis-
charge, and selection bias in any type of protocol in which that
is the case is certainly recognized as a problem. The NSQIP is
a real-time snapshot of what is happening, and the administrative
database is, again, a nonelective submission of data, usually elec-
tronically. The STS database is helpful, but it is not an intent-to-
treat, prospective registration of patients that in most assessments
would give one a clearly accurate assessment of what is occurring.
Do you want to comment on that?
DrKozower.You are absolutely correct. The only point I would
add is that the latest version of the database differentiates between
major and minor procedures and requires that all major procedures
be reported. External audits are being used to verify the accuracy
of the data submitted and to verify that major cases, perhaps with
poor outcomes, are not being omitted. The results these audits will
obviously be extremely important.
Dr Sugarbaker. I would just say, if you know, particularly in
the cardiac world, what pressure institutions are under for out-
comes, you could be concerned that in particular centers tremen-
dous pressure exists to produce excellent outcomes, not that
anybody is going to alter that, but there is tremendous pressure.
Dr Alexander Krupnick (St. Louis, Mo). Going along with Dr
Sugarbaker’s question, is 1 of these databases audited by
insurance companies? In other words, does this reporting affect re-
imbursement? Could some of the comorbidities be overexagger-
ated in 1 database and reported more accurately in others? Is
there any financial incentive for differential reporting between
the databases and could that in any way contribute toward the
discrepancy?
Dr Kozower. Excellent question. The NIS actually uses the
same discharge abstract data that is used to generate charges. So,
if there is intentional gamesmanship, it is truly fraud. However,
we all know that issues exist with the accuracy of administrative
data. The more we study our own administrative data, from the
University Healthsystem Consortium, the more issues we find.
For the STS database, the current audits have looked quite good.
Fortunately, no current advantage exists for ‘‘gaming’’ the systemgery c November 2012
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sure increases and the insurance companies ‘‘tighten the screws,’’
there will be some increased pressure to perform.
Dr Sugarbaker. Particularly because the STS database is now
being made available to certain insurers to assess quality for par-
ticular institutions regionally.
Dr Thomas K. Waddell (Toronto, Ontario, Canada). I had the
same concerns, but when I first read this abstract, Benji, and I know
you are such a methodological purist, I thought the purpose of this
study was to actually try to study the various qualities of different
types of databases, not to actually talk about that this proves that
this type of surgeon is better to do this operation in this type of
hospital.
So, returning to a good question; that is, can we look at the qual-
ity of data in these 3 databases, are there actually any overlapping
patient data that are in all 3 data sets? Is it possible to perform pa-
tient-level linkage? Is it possible to perform hospital-level linkage?
That would get to David’s question about what is the actual miss-
ing patient who often had, perhaps, died. Also, even to go a little bit
more broadly, could you actually construct some sort of quality as-
sessment of the data entered by linking to the Centers for Medicare
and Medicaid Services data to study items such as the reoperationThe Journal of Thoracic and Carrate as a method to judge the quality of not just the STS database
but, in fact, all of these data sets?
Dr Kozower. That is a great question. When I started this pro-
ject, my initial objective was to compare these different databases
at a national level. However, we cannot link them at a patient level
to compare the accuracy of data and reported outcomes such as
mortality, morbidity, and readmission. Although certain hospital
level characteristics can be linked between different databases, pa-
tients are deidentified.
I am sorry, I did not fully catch your question on the Centers for
Medicare and Medicaid Services.
DrWaddell. I was wondering if you could study reoperation as
an outcome metric of quality esophagectomy, or whatever, and
then use the Centers for Medicare and Medicaid Services data to
validate that; how many patients actually were there bills or
charges for associated with that reoperation. That could be one
method to validate. If you find that everybody is billing for 3 times
more reoperations than they claim to be performing in the STS da-
tabase, that might tell you something.
Dr Kozower. It is an excellent question and we could pool data
from a few hospitals to consider this, but we cannot do it for the
national databases.diovascular Surgery c Volume 144, Number 5 1159
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